3-DIMENSIONAL PHOTON TREATMENT PLANNING FOR CARCINOMA OF THE NASOPHARYNX

被引:39
作者
KUTCHER, GJ
FUKS, Z
BRENNER, H
BROWN, AP
BURMAN, C
CHENG, E
COIA, L
KRIPPNER, K
MANOLIS, JM
MOHAN, R
SIMPSON, JR
URIE, M
VIKRAM, B
WALLACE, R
机构
[1] CHAIM SHEBA MED CTR,TEL HAFHOMER HOSP,IL-52621 TEL HASHOMER,ISRAEL
[2] UNIV PENN,SCH MED,PHILADELPHIA,PA 19104
[3] FOX CHASE CANC INST,PHILADELPHIA,PA 19111
[4] WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110
[5] MASSACHUSETTS GEN HOSP,DEPT RADIAT MED,BOSTON,MA 02114
[6] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[7] BETH ISRAEL MED CTR,DEPT RADIAT ONCOL,NEW YORK,NY 10003
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1991年 / 21卷 / 01期
关键词
NASOPHARYNX; TREATMENT PLANNING; 3-DIMENSIONAL PLANNING;
D O I
10.1016/0360-3016(91)90176-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of 3-D treatment planning for carcinoma of the nasopharynx was assessed in a four institution study. Two patients were worked up and had an extensive number of CT scans on which target volumes and normal tissues were defined. Treatment planning was then performed using state of the art dose planning systems for these patients to assess the value of the new technology. In general, it was demonstrated that multi-field conformal plans could achieve good tumor dose coverage, while at the same time reducing normal tissue doses, compared to standard treatment planning techniques. The role of inhomogeneity corrections, beam energy, and the use of CT vs. simulation films for defining target volumes were also discussed. In addition, techniques to evaluate 3-D plans for the nasopharynx were considered, and some analysis of this problem is presented in this paper.
引用
收藏
页码:169 / 182
页数:14
相关论文
共 16 条
[1]  
BEDWINEK JM, 1987, PRINCIPLES PRACTICES, P492
[2]   FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION [J].
BURMAN, C ;
KUTCHER, GJ ;
EMAMI, B ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :123-135
[3]   REGIONAL STAGE-IV CARCINOMA OF THE NASOPHARYNX TREATED BY AGGRESSIVE RADIOTHERAPY [J].
COOPER, JS ;
DELROWE, J ;
NEWALL, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (11) :1737-1745
[4]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[5]  
FLETCHER GH, 1982, TXB RADIOTHERAPY, P320
[6]   HISTOGRAM REDUCTION METHOD FOR CALCULATING COMPLICATION PROBABILITIES FOR 3-DIMENSIONAL TREATMENT PLANNING EVALUATIONS [J].
KUTCHER, GJ ;
BURMAN, C ;
BREWSTER, L ;
GOITEIN, M ;
MOHAN, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :137-146
[7]   RADIATION TREATMENT OF CANCER OF PHARYNX - WITH SPECIAL REFERENCE TO TELECOBALT THERAPY [J].
LEDERMAN, M ;
MOULD, RF .
BRITISH JOURNAL OF RADIOLOGY, 1968, 41 (484) :251-+
[8]  
MARKS JE, 1982, CANCER-AM CANCER SOC, V50, P1042, DOI 10.1002/1097-0142(19820915)50:6<1042::AID-CNCR2820500604>3.0.CO
[9]  
2-Y
[10]   MEGAVOLTAGE IRRADIATION OF EPITHELIAL TUMORS OF THE NASOPHARYNX [J].
MESIC, JB ;
FLETCHER, GH ;
GOEPFERT, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (04) :447-453